The effect of the selective PAF antagonist BN 52021 on PAF- and antigen-induced bronchial hyper-reactivity and eosinophil accumulation
- 1 March 1988
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 148 (1) , 51-58
- https://doi.org/10.1016/0014-2999(88)90453-0
Abstract
No abstract availableThis publication has 25 references indexed in Scilit:
- Effects of platelet activating factor on the chemotaxis of normodense eosinophils from normal subjectsBiochemical and Biophysical Research Communications, 1987
- Platelet-activating factor. A potent chemotactic and chemokinetic factor for human eosinophils.Journal of Clinical Investigation, 1986
- EFFECTS OF INHALED PLATELET ACTIVATING FACTOR ON PULMONARY FUNCTION AND BRONCHIAL RESPONSIVENESS IN MANThe Lancet, 1986
- ACCUMULATION OF EOSINOPHILS IN RESPONSE TO INTRACUTANEOUS PAF-ACETHER AND ALLERGENS IN MANThe Lancet, 1986
- Role of Platelet-Activating Factor-Acether in Mediating Guinea Pig AnaphylaxisScience, 1986
- ASTHMA AS AN AXON REFLEXThe Lancet, 1986
- From parasites to allergy: a second receptor for IgEImmunology Today, 1986
- PAF-acether specific binding sites: 2. Design of specific antagonistsTrends in Pharmacological Sciences, 1986
- Release of platelet-activating factor (PAF-acether) and arachidonic acid metabolites from alveolar macrophagesInflammation Research, 1981
- Platelet-Activating Factor (PAF-Acether) Secretion from Platelets: Effect of Aggregating AgentsBritish Journal of Haematology, 1980